Although there is growing evidence that neurotoxic molecules produced by HIV-1 -infected mononuclear phagocytes damage neurons, the precise mechanisms of neuronal attack remain uncertain. One class of cytotoxin involves neuronal injury mediated via the NMDA receptor. We examined blood monocytes and brain mononuclear cells isolated at autopsy from HIV-Iinfected individuals for the ability to release NMDA-like neuronkilling factors. We found that a neurotoxic amine, NTox, was produced by blood monocytes and by brain mononuclear phagocytes infected with retrovirus. In vr'vo injections of minute quantities of NTox produced selective damage to hippocampal pyramidal neurons. NTox can be extracted directly from brain tissues infected with HIV-l and showed structural features similar to wasp and spider venoms. In contrast to NTox, HIV-l infection did not increase the release of the NMDA excitotoxin quinolinic acid (QUIN) from mononuclear cells. Although we found modest elevations of QUIN in the CSF of HIV-l-infected individuals, the increases were likely attributable to entry through damaged blood-brain barrier. Taken together, our data pinpoint NTox, rather than QUIN, as a major NMDA receptordirected toxin associated with neuro-AIDS.
1990) or human blood monocytes (Pulliam et al., 3991) . These studies showed that infected mononuclear phagocytes, but not lymphocytes, release neuron-killing factors. Subsequent reports demonstrated that mononuclear phagocytes were a source of cytotoxic agents when activated not only by viral infection but aIso by other immune stimuli, including the vira1 envelope protein gp120 (Colton and Gilbert, 1987; Thery et al,, 1991; Boje and Arora, 1992; Lipton, 1992a; Giulian et al., 1993a) . Although a number of candidate poisons-cytokines, free radicals, nitric oxide, platelet activating factor-were derived from monocytes, there has been uncertainty as to which of these agents is relevant to neuro-AIDS (Gendelman et al., 1994) . We and other investigators have suggested that neurons bearing NMDA receptors are sensitive targets of cytotoxins generated during HIV-1 infection (Giulian et al., 1990; Lipton, 1992a) . Two pertinent neurotoxins with NMDA-like properties are quinolinic acid (QUIN; Schwartz et al., 1983) , found elevated in the CSF of HIV-l-infected individuals (Heyes et al., 1989) , and a neurotoxic amine (referred to here as NTox) reIeased by HIV-l-infected monocytic cell lines (Giulian et al., 1990 (Giulian et al., ,1993a . Although both of these toxins may be brain-damaging agents in neuro-AIDS, no direct evidence exists that HIV-l infection actually drives mononuclear phagocytes to release QUIN or that NTox exists within cells or tissues of infected individuals. In this report, we compare the capacities of blood and brain mononuclear phagocytes to produce factors toxic to NMDA receptor-bearing neurons. Although elevated QUIN levels appear in CSF of HIV-l( +) patients, no increased production by infected mononuclear celIs was detected. In contrast, NTox was found to be released by blood-and brain-derived mononuclear phagocytes recovered from HIV-l-infected individuals. Moreover, NTox was a potent neuron poison in VI'VO, sharing some structural features with the polyamine amide class of wasp and spider venoms.
MATERIALS AND METHODS
Culture of ~n~nonckclea~ cells. Cell lines were cultured in RPMI-1640 with L-glutamine supplemented with 10% fetal bovine serum (FBS) or in N2 media (Bottenstein and Sato, 1979) The PBMCs were washed four times with PBS, pH 7.4, resuspended in RPMT-1640 medium with L-glutamine (Gibco) or N2 media containing 30% fetal bovine serum and 5% IL-2 (Cellular Products, Buffalo, NY), seeded into 100 mm plastic culture dishes at 20 X 10" cells/l0 ml. After a 1 hr incubation at 37°C in an atmosphere of 95% sir/5% CO,, nonadherent cells were removed from culture dishes by gentle washing with three changes of warmed medium and replated at a density of 2 X 10" cells/ml in plastic cuIture dishes for 24 hr. Flow cytometric analyses showed that >90% of these nonadherent cells contained the lymphocyte marker CD45, whereas ~1% were CD14(+) monocytes. Adherent cells were recovered by washes with ice-chilled Ca'+-and Mg2+-free PBS and plated at a density of 1 X 10h/ml. Samples (3 ml of culture media conditioned by cells) were mixed with 100 ng dipicolinic acid (pyridine, 2,6-dicarboxylic acid, DPIC) as an internal standard, loaded onto a glass column packed with DOWEX-1X2, and eluted with 5 ml 6N formic acid. Lyophilized eluants were then mixed with 25 l-~l of Dvridine and 75 ~1 of N-methvl-N-tert-butyldimethylsilyl-trifluoroaceta&le (Pierce, Rockford, IL) ahd heated at 60°C for 30 min. Two microliters of derivatized material were injected for analysis by electron impact ionization mass spectrometry. Although the molecular ion at mass/charge (m/z) 395 was not observed, a fragment ion at m/z 338 (M+-tert-butyl) was the most abundant ion observed in the mass spectra of both silylated QUIN and DPIC. This ion was selected for specific molecular detection and quantitation of the compounds recovered from biological samples. To estimate recovery of QUIN from culture media by GC/MS, 3 ml of culture media were mixed with 3, 10, 30, and 100 ng of QUIN plus 100 ng DPIC in each sample to serve as the internal standard.
After column fractionation and lyophilization, samples then received 100 ng of pyridine 2,4-dicarboxylic acid as an 4.30 mg ketamine, and 0.14 mg acepromazine per 100 gm body weight) and placed in a stereotaxic device. Using aseptic technique, the scalp was reflected and burr holes were placed lateral to the midline.
A microsyringe with a 26 gauge needle was then inserted down 2.9 mm from the brain's surface, at a distance of 4.5 mm caudal to bregma, 3.0 mm lateral to the midIine into the hippocampus; concentrated fractions reconstituted in artificial CSF, pH 7.4, were infused in 1 .O ~1 over a period of 4 min. The scalp was closed with wound clips, and recovery was monitored under a heat lamp for 60 min before returning to a home cage.
Histology. Five days after brain injections, animals received overdoses of intraperitoneal anesthetic and were perfused with 60 ml of PBS containing 2 U/ml of heparin followed by 60 ml of 3% formaldehyde in PBS. Brain tissues were then placed in buffered 3% formaldehyde at 4°C overnight and processed for histology. Paraffin-embedded rat brains were cut into coronal serial sections (8 pm thickness) and stained using a modified degenerative stain (Fink and Heimer, 1967) RESULTS QUIN, a dicarboxylic acid, and NTox, a neurotoxic amine, are two agents thought to contribute to the neuronal pathology observed during I-IIV-1 infection, Although both of these factors readily destroyed ciIiary or hippocampal neurons in v&o, culture conditions did influence neurotoxic potencies in different ways. QUIN, for example, showed an ED,,, of -25 nM with ciliary neurons grown in chemically defined culture media that increased to 30 PM when medium was supplemented with dialyzed 10% newborn calf serum. NTox, in contrast, was a more potent agent with an ED,, -20 PM, and remained unaffected by the presence of serum (Fig.  lA) , QUIN killing of hippocampal neurons (grown atop a feeder layer of astroglia) required micromolar concentrations (ED,, = 10 PM), whereas NTox readily destroyed neurofilament( +) MAP-2(+) hippocampal cells in the low picomolar range (ED,, = 50 PM; Fig. 1B) . Neuron killing by both QUIN and NTox was blocked by 10 PM of AP7 or MK-802, antagonists to the NMDA receptor channel complex (Fig. lC,D) . May 15, 1996, 16(10) NTox demonstrates greater neuron-killing capacity with ED,, values estimated in < 100 PM. In contrast, quinolinic acid shows similar effects at -20 nM. QUIN toxicity was further affected by the presence of 10% dialyzed newborn calf serum (CS), which decreased its ED,, to -30 PM, Similar effects were not observed for NTox. B, Dose-response curves show -lOO,OOO-fold difference in potency for NTox and QUIN using embryonic hippocampal neurons as targets, C, D, Both neurotoxins are inhibited in either culture system by 10 pM of the NMDA receptor blockers AP7 or MK-801 (MK801).
Concentrations of 1 PM QUIN and 1 nM of NTox were used.
Neurotoxins released by HIV-l-infected cell lines
Earlier studies (Giulian et al., 1990 (Giulian et al., , 1993a have shown that human monocytic cell lines infected with HIV-1 released NTox ( Fig. 2A) . To determine whether these cells secreted other neurotoxic agents, we monitored QUIN in conditioned media from HIV-l(+) THP-1 and U937 cells. Using both radioenzymatic and GC/MS detection methods (Fig. 3) , we found that there were no significant differences in the amount of QUIN released by infected and noninfected cells (Table 1) . There was no correlation between the presence of neurotoxic activity in culture media and the measured levels of QUIN (Fig. B) . Because QUIN bound to strong anionic exchangers such as DOWEX-2, and NTox bound to strong cationic exchangers such as SP-Sephadex, it was possible to show that neurotoxic activity in culture media was entirely attributable to NTox (Fig* 2A) , QUIN is a metabolite of tryptophan and appears as an intermediary product of the kynurenine degradation pathway. It has been proposed that HIV-l infection of mononuclear cells might alter tryptophan or kynurenine metabolism to increase QUIN production (Heyes et al., 1992) . Although we did not detect elevations of QUIN in mononuclear cells infected with virus, it remained possible that alternative culture conditions might boost the biosynthetic capacity by infected cells. An initial step in the QUIN pathway involves the flavin-dependent enzyme indoleamine 2,3-dioxygenase (IDQ), which converts tryptophan to N-formylkynurenine.
Because the cytokine interferon y (IFNy) can induce IDO, it might also accelerate production of QUIN (Saito et al., 1993) . We found that concentrations of IFNy in the physiological range (400 units/ml) did not stimulate THP-1 or U937 cells to produce QUIN. Very high cytokine concentrations (~200 units/ml of IFNy), however, did elicit QUIN (Fig. 2C ), but not from HIV-l-infected cells (Fig. 2C) . We also incubated infected and noninfected monocytic cells with various QUIN precursors, including tryptophan, kynurenine, and 3-hydroxyanthranilic acid (3-HANA). Media supplementation of tryptophan or its metabolites did not alter the ability of HIV-linfected cells to produce QUIN (Fig. Zo) . Overall, these experiments showed that QUIN production by infected mononuclear phagocytes remained low despite IFNy stimulation or excess concentrations of biosynthetic precursors.
Infected blood cells release neurotoxins
Although cultured monocytic cell lines released neuron poisons after exposure to HIV-l in v&q it remained uncertain whether mononuclear cells actually produced neuron-killing agents within HIV-l-infected individuals. To address this question, we monitored freshly isolated blood cells collected from volunteers with and without HIV-l infection for the ability to produce neurotoxins. Enriched preparations of monocytes or lymphocytes were coded and placed in culture for 72 hr (10" cells/ml); media conditioned by these cell preparations were then screened for neurotoxic activity using cultured neurons as targets. Monocytes from the blood of HIV-l-infected adults produced neuron-killing activity that was dose-dependent and was not found among blood cells of normal adult volunteers (Fig. u--C) . From randomized, coded samples, we found APS-sensitive neurotoxic activity in 14 of 16 blood monocyte cultures from HIV-l-infected individuals but none in lymphocyte cultures prepared from the same individuals. Importantly, coded monocytes isolated from normal individuals (O/6) were free of neuron poisons (Fig. 4A,C ). In all samples tested, the neurotoxic activity released by HIV-l-infected monocytes was identified as NTox by ion exchange chromatography and May 15, 1996, 16(10) could be separated from QUIN The estimated ED,, for media condltloned by monocytes of HIV-1( +) mdlvlduals (lo6 cells/ml for 72 hr) was 3% ? 0 5% volume m the clhary neuron assay with neurons grown m the presence of serum May 15, 1996, 76(10) 
C, Graph shows the dose-dependent killing of neurons by media conditioned by monocytes isolated from infected [HIV( +)] or uninfected [HIV( -)] individuals. D. Blood cells isolated from an HIV-l-infected donor
show that increasing cell number increases the amount of NTox uroduced, but has no effect on the measured levels of QUIN. Blood cells from a normal donor [HIV( -)] have no significant neurotoxic activity. The highbasal levels of QUIN found in these culture media come from the supplements (fetal bovine sera, giant cell derived growth factors) used to maintain productive HIV-l infection among human blood cells.
To enhance cell survival and to promote productive viral infection, supplements of fetal bovine sera and GCT cell-derived growth factors variably raised the basal level of QUIN in leukocyte culture media between 1 and 5 PM. In general, QUIN production by these human blood preparations were below QUIN levels intrinsic to the culture media. Increasing the number of HIV-l(+) mononuclear cells in culture increased the amount of NTox released without elevating QUIN concentrations above background media levels (Fig. 40) . Based on these experiments, we concluded that essentially all NMDA-like neurotoxic activity released by blood cells cultured from HIV-l(+) individuals was attributable to NTox.
Neurotoxic agents released by HIV-1 -infected brain cells
To determine whether mononuclear brain cells also had the ability to secrete neurotoxins, we isolated microglia from human neocortex. As reported (Giulian et al., 1995a) , gray matter from normal adult human brain provided highly enriched preparations of viable microglia (>98% homogeneity) if obtained within a 6 hr post mortem interval. These cells, when isolated from normal brain, were CD4(+) and covered with spinous projections (Fig.  54,D) . Although normal brain-derived microglia did not show spontaneous release of neuron poisons (Fig. 5B) , these cells become neurotoxic after infection with HIV-l in vitro or after exposure to 1 nM gp120 (Fig. 5B) . No QUIN levels above basal concentrations were found in culture media conditioned by infected or gpl20-stimulated human microglia (Fig. 5C) . As recently described (Giulian et al., 1995b) , mononuclear phagocytes isolated from brains of HIV-l-infected individuals consisted of mixed-cell populations, including both microglia with spinous morphology (Fig. 5D ) and blood-borne macrophages with ruffled surfaces (Fig. 5E ). [These ruffled cells were estimated to make up >5% of the total brain mononuclear phagocyte population recovered from infected CNS (Giulian et al., 1995b) .] Unlike mononuclear phagocytes from normal brain, cells derived from HIV-linfected brain released NTox, which was detected within 3 d of culture (Fig. 5F ). There was no significant QUIN production by these same brain-cell preparations.
Neurotoxins found within HIV-1 -infected brain tissues Because brain cells released NTox after HIV-l infection, we anticipated that this same neurotoxic factor could be recovered from HIV-l-infected brain tissues. As shown in Figure 6 , ultrafiltrates from viral-infected, but not normal, gray matter contained NTox. Biochemical properties, including stability after acid hydrolysis, binding to cationic exchange resins, pH-dependent extraction into ethyl acetate, and copurification using RP-HPLC, confirmed that NTox released by infected cells in culture was indistinguishable from the toxin extracted from the CNS ( Fig. 6C ; see below).
As noted, HIV-l-infected human cell lines, blood monocytes, or brain microglia did not release significant amounts of QUIN. Moreover, brain tissue levels of QUIN were nearly identical in samples tested (infected brain ultrafiltrates containing 30 + 5 nM QUIN and normal brain ultrafiltrates containing 25 2 4 nM>. Such Figure 5 . A, Photomicrograph of human microglia isolated from normal adult human brain demonstrates the presence of CD4 surface receptor by immunoperoxidase staining. CD4 receptor provides the site for HIV-l infection of mononuclear cells. B, The neurotoxic activity of human microglia isolated from normal brain can be elicited by exposure to 1 nM gp120 or by in vitro infection with HIV-l. The mock infection control (HIV-1 control) or gp120 alone cpPl20 only) do not cause neuron damage. Fractionation by ion exchange chromatography confirmed that such neurotoxic activity is entirely attributable to NTox. C, In contrast to NTox, quinolinate acid production is not altered in human microglia by exposure to gp120 or HIV-L D, Electron photomicrograph of scanning EM that shows a microglial cell isolated from human brains after a rapid autopsy. Human microglia are process-bearing and covered with spines (2500X magnification). E, In addition to microglia, HIV-l-infected brains also contain invading macrophages, which can be identified by ruffled surfaces (2500X magnification). F, Mononuclear phagocytes isolated from HIV-l-infected brain (lo6 cells/ml) show increasing amounts of neurotoxic activity over time. Under identical conditions, microglia from normal brains did not release neuron-killing factors (data not shown). CNS further, we dispersed frozen gray matter by somcatlon (1 10 wtivol m dH,O) and removed particulate material by centrlfugatlon Bulk punfication was then performed by ultrafiltration of the voluble fraction, by extractions mto ethyl acetate at pH 10 5, by acid hydrolysis, and by sequential gradient chromatography using RP-HPLC A peak detected by UV at 265 nm eluted at -14% acetomtrlle from Cl8 RP-HPLC and contained all recovered neurotoxlc activity (Fig 6&C) Importantly, this peak of biological activity was estimated to be >lOO,OOO-fold enriched when compared with brain ultrafiltrates (Fig 60) show that the ED,,, = 10 PM m the ultrafiltrate (Fzlfrufe) compared with 10 PM for highly purified NTox after Cl8 RP-HPLC From such preparations, we estimate >lOO,OOO-fold purlficatlon The phenohc content was estimated by UV,,, at 265 nm against a standard curve of tyramme A slmllar result way obtained when values were normalized to dmme content measured against a tyramme curve using the fluorescamme method Table 1 . Quinotinic acid release by HIV-l infected cells A Radioenzymatic GC/mass spectrometric detection detection THP-1 13.0 -+ 3.7 nM (rt= 6) 13.9 -c-0.9 (3) THP-l/HIV 13.6 " 2.3 nM (7) 15.9 -t-2.3 (3) H9 7.7 5 2.1 nM (4) 37.9 2 1.7 (2) H91HIV 6.2 2 0.9 nM (4) 10.8 2 2.0 (2) u937 8.8 + 3.6 nM (5) 16.8 2 9.4 (2) U937/HIV 9.0 2 2.0 nM (7) 13.8 4 1.8 (2) Levels were estimated in serum-free culture media conditioned for 48 hr at a density of 10" cells/ml of medium (number of independent determinations). NTox recovered from human brain has a mass <lOOO Da and a lipophilic quality that is pH-sensitive (extraction into ethyl acetate at increasingly alkaline pH); step-gradient extractions with pH increasing from 8.0 to 11.0 suggested an isoelectric point between 9.5 and 10.5. Copurification studies confirmed that NTox from HIV-linfected human brain was identical to that from HIV-l-infected cell lines (Fig. 6C) . Acetylation with acetic anhydride or derivatization with PFPA indicated the presence of -NH, groups, whereas inactivation by plasma amine oxidase uncovered terminal amines (Fig.  84,B ). There were no apparent -COOH groups, because NTox was resistant to esterification with acidified butanol (Fig. &1) ; NTox was not sensitive to t-amino acid oxidase or lipase (Fig. 8B) arguing against simple amino acids or lipids as the toxic factor. Resistance to acid hydrolysis (24 hr, 105°C in 6N HCl) ruled out a number of molecules, including proteins and peptides, as the neuron-killing agent. Although unaltered by mild reduction with palladium, NTox did lose activity after hydrogenation by rhodium, which suggested the presence of double-bond structures such as phenolic or pyridine rings (Fig. &4) . Inactivation of toxic activity by both polyphenol oxidase (pH 6.5, 37"C, 30 min) and methylation with diazomethane favored the presence of phenols (Fig. 8B) . Although a class of potent polyamine amide neurotoxins (Fig. SC) has some biological and structural properties in common with NTox, these venoms produced by wasps and spiders require peptide bonds for biological activity (Asami et al., 1989) . Despite the fact that chemical and enzymatic modifications indicated NTox to be a phenolic amine with lipophilic properties (Fig. 8C) , additional work will be needed to determine whether NTox, in fact, represents a new class of mammalian-derived neurotoxin. Quinolinic Acid in CSF (nM)
-
Brain-derived neurotoxin acts on NMDA receptor-bearing neurons NTox destroyed cultured neurons bearing the NMDA receptor ( Fig.   9A ) which, as noted above, could be blocked by NMDA antagonists.
Because of the potential for therapeutic interventions, we sought to define the relationship of NTox to the NMDA receptor by comparing the ability of specific drugs, which act at select sites of the receptor complex, with block neurotoxicity. Highly purified NTox was applied to neuron cultures to establish a dose curve with a saturating response; we then examined the effects of increasing concentrations (ranging from 1 nM to 10 ELM) of AP5 (NMDA receptor site) and MK-801 (NMDA channel site) on the general shape of the established toxicity response curve. As shown in Figure  9 , AP5 shifted the ED,, of NTox, whereas MK-801 did not. Such data suggested that the neurotoxin competed with the NMDA receptor site as shown by a shift of the neuron-killing response to the right; in contrast, noncompetitive interactions between the neuro- toxin and MK-801 altered saturation of responses (Goldstein et al,, 1974) . A plot of ratios of ED,, values (Arunlakshana and Schild, 1959) showed a linear relationship for AP5, again implicating a direct May 15, 1996, 76(10) whereas strong reducing conditions with rhodium or methylation by diazomethane eliminated neuron killing. These data suggested the presence of double-bonded ring structures. B, Enzymatic treatments showed NTox sensitivity to polyphenol oxidase and plasma amine oxidase (&IO) but not to L-amino acid oxidase (MO) or lipase. These data suggest that a phenolic ring and terminal amine are required for toxic activity. As a control, enzymatic activity was eliminated by immediate boiling (boil) to confirm specificity of action on the neurotoxin. C, Structural features of NTox. Important features that distinguish NTox from other potent neurotoxins include the lack of carboxyl groups (as found in quinolinic acid), the presence of amine (lacking in phenol), and the lack of peptide bonds (as found in orb spider venom). (I), Hydroxyl group on ring structure suggested by sensitivity to potyphenol oxidase and diazomethane; 0, ring structure suggested by rhodium reduction, UV,,,, and polyphenol oxidase inactivation; 0, lipophilic region indicated elution with RIP-HPLC and organic extractions; 0, amine group indicated by inactivation with ace tylation, PFPA, and plasma amine oxidase.
competition between NTox and AP5 at a common site of binding (Fig. 9E) .
Actions of HIV-1 neurotoxin in vim
If NTox, in fact, played a role in the pathogenesis of human brain injury, it should also demonstrate biological action when infused into the brain. The rationale for hippocampal injections into rats was based on our observations that NMDA receptor(+) hippocampal neurons were particularly sensitive to the toxin in vitro.
After infusion of NTox (derived from gpl20-stimulated THP-1 cells), large numbers of pyknotic and dying pyramidal neurons were apparent 5 d later in the CA1 and CA3 regions of the hippocampus (Fig. 10) . Little cell damage in the hippocampus was produced by injection of an identical, highly purified fraction from unstimulated THP-1 cells (Fig. 10) . Study of animals infused with NTox (100 pmol) showed a uniform pattern of pyknotic neurons (Fig. 1OE ) within 100 pm (rostra1 to caudal) to either side of the injection site. Damage occurred primarily among pyramidal neurons in the CA1 and CA3 regions with sparing of the dentate granule cells and CA2. By contrast, a 60 nmol infusion of QUIN showed total loss of pyramidal cells in CA1 and CA3 without pyknosis. No seizure activity was noted after NTox infusion. We estimated that 100 pmol of NTox produced ~65% loss of CA3 neurons 5 d after stereotaxic infusion compared with about a 10% cell loss after injections of identical nontoxic fraction (Fig. 11) . One nmol of AP5 infused before NTox protected CA3 neurons (Fig. ll) , confirming that NTox targeted NMDA receptor-bearing neurons in viva.
DISCUSSION
The mechanisms by which mononuclear phagocytes attack neurons after HIV-l infection are thought to involve neuron-selective toxins (Eiulian, 1990; Gendelman et al., 1994) . Because NMDA receptor-bearing neurons play a role in cognition and memory, it has been tempting to connect perturbations in NMDA neurotransmission with dementia (Lipton, 1992b) . Two NMDA receptor-mediated neurotoxic agents, QUIN and NTox, have been linked to HIV-l infection through clinical observations (Heyes et al., 1989 (Heyes et al., , 1991 or in vitro modeling (Giulian et al., 1990 (Giulian et al., , 1993a . To explore the role of these two toxic molecules in neuro-AIDS, we determined whether their stimulated production occurred in mononuclear cells isolated from HIV-l -infected individuals. Although blood-derived or brain-derived infected mononuclear phagocytes did not produce excessive amounts of QUIN, we did find marked production of NTox by both blood monocytes and microglia recovered from infected donors. Biochemical studies revealed NTox to be a phenolic amine lacking both peptide bonds and carboxyl groups. Overall, NTox found in HIV-linfected brain was indistinguishable from the microglia-derived or monocyte-derived NTox recovered from culture media as indicated by identical elution profiles with ultrafiltration, ion chromatography, organic extractions, and reverse-phase HPLC. Importantly, NTox concentrations found in HIV-l-infected CNS were similar to those levels capable of inflicting hippocampal damage when infused into animals.
As described here, NMDA receptor blocking agents have neuroprotective effects against NTox in v&o, and an NMDA receptor antagonist dose-response comparisons with QUIN, suggest that NTox is among the most potent of the known NMDA receptor-dependent neuron poisons. Caution, however, must be applied to this interpretation because the experiments reported here involved a multicellular assay system in which the fate of the toxic agent (uptake vs metabolism) was unknown. The structural model for NTox based on functional group analyses by chemical and enzymatic modifications indicated some similarities between NTox and polyamine amides found in orb spider and wasp venoms. Although NTox has functional dependent phenolic groups and a terminal amine, it lacked peptide bonds found in all known polyamine amide venoms. Thus, although similarities exist between the polyamine amides and NTox, the agents were not identical. Other differences between NTox and polyamine amides might exist. For example, current literature indicates that polyamine-containing agents act on the NMDA channel (Asamin et al., 1989; Jasys et al., 1990; Williams et al., 1990) and not the NMDA binding site as proposed for NTox. A more detailed modeling of NTox/receptor interactions awaits further investigation by direct binding assays; structural studies currently under way will help to determine whether NTox, in fact, represents a new class of mammalianderived neuron poison.
Other investigators have proposed that HIV-l infection stimulated release of such mononuclear cell products as nitric oxide, cytokines, platelet activating factor, eicosanoids, and free radicals (Genis et al., 1992; Epstein and Gendelman, 1993). It has not Figure 9 . A, NMDA receptor(+) ciliary neurons survive when grown in the presence of media conditioned by monocytes (10% volume) from a normal volunteer; in contrast, there is a marked loss of NMDARl(+) neurons (B) when exposed to media from an HIV-l-infected individual. Scale bar, 7 pm. C, D, NTox interactions with the NMDA receptor. Using ultrafiltrate from HIV-infected brain, we examined its toxic effects on ciliary neurons with increasing concentrations of AP5, an NMDA receptor antagonist, or MK-801 (MKgol), an NMDA channel blocker. As shown, increasing amounts of AP5 shift dose responses to the right, producing ever larger ED,, values with no change in saturating responses. Such a pattern suggests there is a direct competition between NTox and AP5 to elicit cell death. Although increasing concentrations of MK-801 block toxicity, the degree of the responses are increasingly reduced, suggesting a noncompetitive relationship between NTox and MK-801. E, A Schild analysis for AF'5 curves indicates a linear relationship, again indicative of competition between neurotoxin and AP5. (The Schild analysis assumes an equilibrium is reached among agonists and receptors that might not occur in a toxicity assay with ongoing loss of cells.) been clear, however, which of these factors were produced in significant amounts in the CNS during HIV-l infection or which actually contributed to neuronal pathology. Human mononuclear cells, for example, have little capacity to synthesize nitric oxide (Denis, 1994) . Although tumor necrosis factor (Y was readily secreted by activated microglia and was found in HIV-l-infected brains, this cytokine has no capacity to kill neurons in vitro (Giulian et al., 1994) . Platelet activating factor (PAF), another potential neurotoxin released by activated monocytes (Kornecki and Ehrlich, 1988) , has been found in low concentrations in CSF of a variety of neurological disorders including patients with HIV-l dementia (Gelbard et al., 1994) ; it remains uncertain, however, whether neuron-damaging concentrations of PAF were produced in brain tissues. Alternatively, some viral proteins have also been described as neuron poisons. Brenneman et al. (1988) have reported that the HIV-l envelop glycoprotein gp120 acted as a direct neuronal toxin, a finding later supported by Dreyer et al. (1990) . However, because cell culture systems used in these experiments were mixtures of neurons and glia, it was not possible to demonstrate direct toxic effects on neurons independent of microglia. Subsequent work using CNS cultures lacking mononuclear phagocytes showed that gp120 was not toxic to neurons but rather served as a stimulus to induce NTox release from mononuclear cells (Giulian et al., 1993a) . Similarly, Lipton (1992a) found that destruction of microglia in retinal cell cultures eliminated the ability of gp120 to kill ganglion cells. With the exception May 15, 1996, 76(10) Distance (microns) Figure 10 . NTox infused directly into rat hippocampus kills neurons in viva Five days after injections, neurons most sensitive to NTox included the pyramidal cells of the CA1 and CA3 regions. A, Fink-Heimer degeneration stain of CA1 neurons after NTox infusion (purified from media conditioned by gpl20-stimulated THP-1 cells). B, In contrast, contralateral hippocampus infused with a nontoxic control fraction (recovered from media conditioned by unstimulated THP-1 cells) showed little cell damage. C, Cresyl violet-stained rat hippocampus (CA3 region) after stereotaxic injections also showed far more dying, pyknotic neurons after infusion of NTox when compared with the contralateral hippocampus control infusion (D; Scale bar, 40 pm). E, Measurement of cell loss in the CA3 region after infusion of NTox in serial sections (8 q thick) rostra1 and caudal to the site of injection. As shown, -60% neuronal loss appeared within 150 wrn of the site of toxin infusion. One microliter of artificial CSF with or without NTox was injected over a 4 min period at 2.9 mm from the brain's surface, at a distance of 4.5 mm caudal to bregma, 3.0 mm lateral to the midline into the hippocampus. We estimate -100 pmol of NTox were contained in the 1 ~1 fluid volume injected into the hippocampus. Sabatier et al., 1991) other HIV-l proteins have no neuronkilling capacity (Giulian et al., 1993a) . The question of QUIN production during HIV-l infection was addressed here using two different approaches. First, we showed that HIV-l-infected mononuclear phagocytes or microglia did not have an enhanced capacity to produce or release QUIN. In the case of HIV-l-infected THP-1 cells, we also demonstrated that exposure to three bioprecursors of QUIN, i.e., tryptophan, kynurenine, and 3-hydroxyanthranilate, did not cause synthesis beyond control levels. Similar data were also obtained from infected blood monocytes (data not shown). These results must be contrasted with several reports by Heyes and coworkers (1989, 1991) , who had provided indirect evidence favoring infiltrating HIV-l-infected macrophages as the source of the often dramatic increases in CSF and brain tissue QUIN levels in AIDS (Heyes et al., 1992) . We did confirm elevations in CSF QUIN concentrations during HIV-l infections, although the increases were far lower in magnitude than those reported previously (Heyes et al., 1989) . It should be noted, however, that the HIV-l(+) patients assessed here were volunteer outpatients, and not the severely demented, hospitalized population used in other studies (Heyes et Figure 11 . The in vivo action of NTox can be blocked by preinfusion of 1 nmol of AP5 prepared in 1~1 artificial CSF (A) before NTox injection. In contrast, a control preinfusion with 1 ~1 artificial CSF did not block hippocampal injury as shown in B. Quantitative measure of CA3 neuronal damage (C) shows a 60-70% after-NTox infusion with -10% pyramidal cell loss seen in control injections (Student's t test; p < 0.0001). Blockade with AI'5 reduces cell loss to control levels. Cell counts were obtained at 100 pm rostral and caudal to the site of injection from S-pm-thick sections stained with cresyl violet. al., 1989, 1992) . Importantly, the highest levels of CSF QUIN described here were in those samples with the highest levels of serum albumin. The most likely explanation for this correlation was that both QUIN and albumin entered the CSF through defects in the blood-brain barrier, perhaps the result of previous CNS pathologies such as bacterial infections, parasitic abscesses, or neoplasms. Such defects have been suggested by Petit0 and Cash (1992) based on increased serum protein deposits in brain tissues of patients with AIDS dementia. The idea that changes in cerebral QUIN concentrations reflect abnormal blood-brain barrier is further supported by the fact that disease states with the highest reported levels of CSF QUIN involved meningeal pathology, such as bacterial, carcinomatous, or fungal meningitides (Heyes and Markey, 1988; Heyes and Lackner, 1990; Heyes et al., 1989 Heyes et al., , 1992 . Although our data do not provide a satisfactory answer regarding the possible participation of raised QUIN levels in the pathophysiology of AIDS, steady exposure to elevated QUIN concentrations could lead to cognitive decline. Moreover, sustained hyperphysiological levels of QUIN (Whetsell and Schwartz, 1989 ) might result in enhanced vulnerability of NMDA receptor-bearing cells to indirect excitotoxic insults (Beal et al., 1991) . If this were true, it follows that the use of pharmacological
